Olink Proteomics announces a new oncology-focused biomarker panel that expands its protein library to over 1100 high-quality assays

Document -

Olink Proteomics announces a new oncology-focused biomarker panel that expands its protein library to over 1100 high-quality assays

Olink Proteomics today announced the launch of Olink® ONCOLOGY III, a new oncology-focused biomarker panel that complements and expands on Olink's growing portfolio of thoroughly validated assays, extending the power of the Olink platform for discovery-scale applications to 1164 different human protein biomarkers.
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • File format: .pdf
Download

Contacts

Gary Franklin

Press contact Marketing Communications Manager Marketing Communications +46 18 444 39 71

Related content

Olink Proteomics announces a new oncology-focused biomarker panel that expands its protein library to over 1100 high-quality assays

Olink Proteomics today announced the launch of Olink® ONCOLOGY III, a new oncology-focused biomarker panel that complements and expands on Olink's growing portfolio of thoroughly validated assays, extending the power of the Olink platform for discovery-scale applications to 1164 different human protein biomarkers.